Universal Health Services Inkomsten in het verleden
Verleden criteriumcontroles 4/6
De winst van Universal Health Services is gedaald met een gemiddeld jaarlijks percentage van -0.7%, terwijl de winst van de Healthcare -industrie jaarlijks groeide met 5.4%. De inkomsten zijn groeide met een gemiddeld percentage van 6.5% per jaar. Het rendement op het eigen vermogen Universal Health Services bedraagt 15.6% en de nettomarge bedraagt 6.7%.
Belangrijke informatie
-0.7%
Groei van de winst
5.7%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 6.5% |
| Rendement op eigen vermogen | 15.6% |
| Nettomarge | 6.7% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Nov 10
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Sep 26Universal Health Services: Stock Has Lots Of Upside Runway
Sep 17Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Aug 10We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt
Jul 26Universal Health Services: An Underpriced Healthy Business
Jul 04Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?
Jun 25Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Jun 10This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate
May 09Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 26Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Apr 17Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 01Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Feb 20Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Feb 05With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For
Jan 09Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 48% Undervaluation?
Dec 13What Does Universal Health Services, Inc.'s (NYSE:UHS) Share Price Indicate?
Nov 02Capital Allocation Trends At Universal Health Services (NYSE:UHS) Aren't Ideal
Oct 15Universal Health Services (NYSE:UHS) Takes On Some Risk With Its Use Of Debt
Sep 28Universal Health Services: Seeking A Cure For Flat Performance
Sep 11Is Universal Health Services, Inc. (NYSE:UHS) Potentially Undervalued?
Jul 23Universal Health Services: Business Is On The Mend
Jul 12Returns On Capital Signal Tricky Times Ahead For Universal Health Services (NYSE:UHS)
Jul 10Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Jun 26Calculating The Fair Value Of Universal Health Services, Inc. (NYSE:UHS)
May 28Should You Think About Buying Universal Health Services, Inc. (NYSE:UHS) Now?
Apr 23Universal Health Services (NYSE:UHS) Could Be Struggling To Allocate Capital
Apr 07Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Mar 23Universal Health Services Q4 2022 Earnings Preview
Feb 24Is Universal Health Services, Inc. (NYSE:UHS) Trading At A 31% Discount?
Feb 14Universal Health: Retain Buy As Systematic Defensive Overlay
Feb 04Universal Health Services declares $0.20 dividend
Jan 18Universal Health Services (NYSE:UHS) Will Be Hoping To Turn Its Returns On Capital Around
Jan 05Universal Health Services upgraded at Wells Fargo on improving operating environment
Jan 03Is It Too Late To Consider Buying Universal Health Services, Inc. (NYSE:UHS)?
Dec 21Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Dec 08Universal Health Services: Attractive Even In Light Of Cost Concerns
Nov 14Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 50% Undervaluation?
Nov 10Opbrengsten en kosten
Opbrengsten en kosten
Hoe Universal Health Services geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 15,418 | 1,026 | 143 | 0 |
| 30 Jun 24 | 15,018 | 934 | 142 | 0 |
| 31 Mar 24 | 14,658 | 816 | 142 | 0 |
| 31 Dec 23 | 14,282 | 717 | 141 | 0 |
| 30 Sep 23 | 14,025 | 676 | 140 | 0 |
| 30 Jun 23 | 13,799 | 692 | 138 | 0 |
| 31 Mar 23 | 13,574 | 684 | 135 | 0 |
| 31 Dec 22 | 13,399 | 675 | 132 | 0 |
| 30 Sep 22 | 13,228 | 739 | 127 | 0 |
| 30 Jun 22 | 13,048 | 774 | 122 | 0 |
| 31 Mar 22 | 12,922 | 935 | 120 | 0 |
| 31 Dec 21 | 12,642 | 990 | 119 | 0 |
| 30 Sep 21 | 12,454 | 1,059 | 120 | 0 |
| 30 Jun 21 | 12,210 | 1,081 | 120 | 0 |
| 31 Mar 21 | 11,742 | 1,008 | 119 | 0 |
| 31 Dec 20 | 11,559 | 941 | 116 | 0 |
| 30 Sep 20 | 11,368 | 878 | 112 | 0 |
| 30 Jun 20 | 11,278 | 734 | 112 | 0 |
| 31 Mar 20 | 11,404 | 721 | 110 | 0 |
| 31 Dec 19 | 11,378 | 813 | 108 | 0 |
| 30 Sep 19 | 11,237 | 726 | 106 | 0 |
| 30 Jun 19 | 11,063 | 801 | 105 | 0 |
| 31 Mar 19 | 10,889 | 789 | 106 | 0 |
| 31 Dec 18 | 10,772 | 779 | 106 | 0 |
| 30 Sep 18 | 10,661 | 840 | 106 | 0 |
| 30 Jun 18 | 10,554 | 810 | 106 | 0 |
| 31 Mar 18 | 10,485 | 770 | 105 | 0 |
| 31 Dec 17 | 10,410 | 752 | 103 | 0 |
| 30 Sep 17 | 10,243 | 707 | 102 | 0 |
| 30 Jun 17 | 10,111 | 717 | 99 | 0 |
| 31 Mar 17 | 9,929 | 717 | 98 | 0 |
| 31 Dec 16 | 9,766 | 702 | 97 | 0 |
| 30 Sep 16 | 9,606 | 702 | 97 | 0 |
| 30 Jun 16 | 9,424 | 700 | 98 | 0 |
| 31 Mar 16 | 9,268 | 697 | 97 | 0 |
| 31 Dec 15 | 9,043 | 680 | 95 | 0 |
| 30 Sep 15 | 8,905 | 679 | 94 | 0 |
| 30 Jun 15 | 8,716 | 612 | 93 | 0 |
| 31 Mar 15 | 8,492 | 581 | 94 | 0 |
| 31 Dec 14 | 8,205 | 545 | 94 | 0 |
| 30 Sep 14 | 7,830 | 497 | 96 | 0 |
| 30 Jun 14 | 7,607 | 529 | 96 | 0 |
| 31 Mar 14 | 7,391 | 529 | 96 | 0 |
| 31 Dec 13 | 7,368 | 510 | 98 | 0 |
Kwaliteitswinsten: UHS heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (6.7%) UHS } zijn hoger dan vorig jaar (4.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van UHS is de afgelopen 5 jaar met 0.7% per jaar gedaald.
Versnelling van de groei: De winstgroei van UHS over het afgelopen jaar ( 51.8% ) overtreft het 5-jarig gemiddelde ( -0.7% per jaar).
Winst versus industrie: De winstgroei UHS over het afgelopen jaar ( 51.8% ) overtrof de Healthcare -sector 10.3%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 15.6% ) van UHS wordt als laag beschouwd.